Skip to content

Clinical trials

Recruiting Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Recruiting Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20142
20172
20192
20205
20211
20227
202311
202411
202538
202627

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting107

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
AstraZeneca3
First Affiliated Hospital of Fujian Medical University3
Chinese University of Hong Kong2
European Institute of Oncology2
Fox Chase Cancer Center2
Imperial College London2
Novartis Pharmaceuticals2
Shanghai Zhongshan Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma107
Prostatic Neoplasms47
Stomach Neoplasms14
Neoplasms12
Carcinoma, Non-Small-Cell Lung11
Pancreatic Neoplasms8
Carcinoma7
Esophageal Neoplasms7
Neoplasm Metastasis7
Carcinoma, Squamous Cell6

Trials

Showing 51 to 75 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.